Clinical Trials Browser

Terminated × Interventional × efatutazone × Clear all

NCT00986440 2020-11-05

Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy

Phase 2 Terminated

84 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

NCT00603941 2020-09-16

A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel

Phase 1/2 Terminated

19 enrolled 13 charts

EndocrineHead & Neck

Neoplasms, Thyroid Carcinoma, Anaplastic

NCT01504490 2017-02-14

Phase I Study of CS-7017 and Bexarotene

Phase 1 Terminated

LymphoidPlasma cell

Lymphoma, Multiple Myeloma